News by Subject Policy & Ethics

Pre-treatment T2-weighted MRI texture features can predict NAC response with reasonable accuracy.

Anti-LAT1 monoclonal antibodies significantly inhibited in vitro cell proliferation and in vivo tumor growth of naLAT1/3T3 cells in nude mice, demonstrating LAT1 to be a promising anti-cancer target

These Oncotarget data demonstrate that local delivery of tumor-specific T-cells is an efficient option to convert tumors that are unresponsive to checkpoint inhibitors to permit tumor cures.

The authors developed and analytically validated a new droplet digital PCR -based assay for HPV16 circulating tumor DNA

In 2018, there were over 2 million cases and 0.6 million deaths from breast cancer (BC), making it the most common cancer globally among women.

Twenty months after declaring a climate emergency and establishing a set of vital signs for the Earth, a coalition headed by two Oregon State University researchers says the updated vital signs "largely reflect the consequences of unrelenting business as usual."

This Oncotarget study confirms the upregulation of TERT in primary glioblastomas while all GABP proteins rise with the malignancy of the gliomas.